Prosecution Insights
Last updated: August 18, 2026

Examiner: NGUYEN, NAM P

Tech Center 1600 • Art Units: 1641 1677 1678

This examiner grants 55% of resolved cases

Performance Statistics

54.7%
Allow Rate
-5.3% vs TC avg
383
Total Applications
+47.4%
Interview Lift
1330
Avg Prosecution Days
Based on 333 resolved cases, 2023–2026

Rejection Statute Breakdown

5.1%
§101 Eligibility
15.3%
§102 Novelty
37.1%
§103 Obviousness
24.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18412316 USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS Non-Final OA SONY GROUP CORPORATION
18341906 METHOD Non-Final OA Oxford Nanopore Technologies PLC
17259601 INTRAMOLECULAR KINETIC PROBES Final Rejection The Regents of the University of Michigan
18480489 TEMPORAL TRAUMATIC BRAIN INJURY BIOMARKERS AND METHODS OF USE THEREOF Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
16523871 POLYMERIC TANDEM DYES HAVING PENDANT NARROW EMISSION ACCEPTOR Final Rejection Becton, Dickinson and Company
16487670 BIOMATERIAL IMMOBILIZING METHOD AND USES THEREOF Non-Final OA MITSUBISHI GAS CHEMICAL COMPANY, INC.
18339799 METHOD FOR DETECTING AN ANALYTE OF INTEREST IN A SAMPLE Non-Final OA Roche Diagnostics Operations, Inc.
16931599 HYPERCROSSLINKING WITH DIAMINE CROSSLINKERS Final Rejection Roche Diagnostics Operations, Inc.
16599480 SUPERPARAMAGNETIC AND HIGHLY POROUS POLYMER PARTICLES FOR DIAGNOSTIC APPLICATIONS Final Rejection Roche Diagnostics Operations, Inc.
17265756 COMPOSITIONS AND METHODS FOR DETECTION AND IMAGING OF AMYLOID FIBRILS, AMYLOID PLAQUES, RNA, AND NUCLEOLI Final Rejection The University of Hong Kong
18268034 BLOOD-BASED PROTEIN BIOMARKER PANEL FOR EARLY AND ACCURATE DETECTION OF CANCER Non-Final OA The Brigham and Women`s Hospital, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month